This compound is a chemical compound used as an intermediate in the synthesis of ibrutinib. It is a pharmaceutical intermediate with a complex polycyclic structure containing amine and ether functional groups.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1022150-12-4
3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
pharmaceutical intermediate
4-Bromo-6-methyl-2-nitropyridin-3-ol
pharmaceutical intermediate
Tert-Butyl 2,7-diazaspiro[3.5]nonane-7-carboxylate--hydrogen chloride (1/1)
pharmaceutical intermediate
4-Fluoro-4-methylpiperidine hydrochloride
pharmaceutical intermediate
(| centR)-|A-(methylamino)benzenepropanol
pharmaceutical intermediate
(R)-3-(4-Phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine dihydrochloride
pharmaceutical intermediate
Ibrutinib acetyl impurity
pharmaceutical impurity standard
Ibrutinib
pharmaceutical raw material
3-(4-phenoxyphenyl)-1-[(3R)-piperidin-3-yl]pyrazolo[3,4-d]pyrimidin-4-amine
GPSQYTDPBDNDGI-MRXNPFEDSA-N
C1C[C@H](CNC1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N